Sign In
Buy FLXN
$25.10
-0.0069 (-0.0275%)
At Close: Jun 22, 2026
Flexion Therapeutics, Inc. (NASDAQ:FLXN): When Will It Breakeven?
12:30pm, Thursday, 02'nd Jul 2020
Flexion Therapeutics, Inc.'s (NASDAQ:FLXN): Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the...
Flexion Therapeutics (FLXN) Initiated with a Buy at H.C. Wainwright - Markets
11:05am, Sunday, 28'th Jun 2020
H.C. Wainwright analyst Patrick Trucchio initiated coverage with a Buy rating on Flexion Therapeutics (FLXN – Research Report) on June
Here’s What Hedge Funds Think About Flexion Therapeutics Inc (FLXN)
05:20pm, Saturday, 27'th Jun 2020
In this article you are going to find out whether hedge funds think Flexion Therapeutics Inc (NASDAQ:FLXN) is a good investment right now. We like to check what the smart money thinks first before doi
Benzinga's Top Upgrades, Downgrades For June 25, 2020
02:10pm, Thursday, 25'th Jun 2020
Upgrades * Credit Suisse changed the rating for Allstate Corp (NYSE: ALL) from Underperform to Neutral. Allstate earned $3.54 in the first quarter, compared to $2.30 in the year-ago quarter. The sto
JPMorgan Chase & Co. Grows Position in Flexion Therapeutics Inc (NASDAQ:FLXN)
06:30am, Wednesday, 24'th Jun 2020
JPMorgan Chase & Co. increased its position in Flexion Therapeutics Inc (NASDAQ:FLXN) by 18.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange C
JPMorgan Chase & Co. Boosts Stake in Flexion Therapeutics Inc (NASDAQ:FLXN)
05:54am, Wednesday, 24'th Jun 2020
JPMorgan Chase & Co. boosted its stake in Flexion Therapeutics Inc (NASDAQ:FLXN) by 18.1% during the first quarter, according to the company in its most recent filing with the SEC. The institutional i
Flexion Therapeutics (NASDAQ:FLXN) Rating Increased to Buy at BidaskClub
01:28am, Sunday, 21'st Jun 2020
Flexion Therapeutics (NASDAQ:FLXN) was upgraded by equities researchers at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Friday, BidAskClub reports. A number of other
Flexion Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
08:30pm, Tuesday, 16'th Jun 2020
BURLINGTON, Mass., June 16, 2020 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate.
Professional choirs may not survive the year, directors warn
04:39am, Tuesday, 16'th Jun 2020
Later this year the MSO plans a grand production of Mahler's 8th symphony. But will they be able to call on the hundreds of singers they need?
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teladoc (TDOC – Research Report),
Wee: New deal will help boost Malaysia’s airports
12:00am, Monday, 15'th Jun 2020
PETALING JAYA: Malaysia is set to have a new operating agreement (OA) for its aviation gateways with the Malaysia Airports Holdings Bhd (MAHB) this year, says Datuk Seri Dr Wee Ka Siong.
13 Reasons Why Was Always Teen Torture Porn
02:39pm, Friday, 12'th Jun 2020
In its final season, the coming-of-age drama is as dark, traumatic, and utterly ridiculous as ever.
Edited Transcript of FLXN earnings conference call or presentation 7-May-20 8:30pm GMT
09:36pm, Thursday, 11'th Jun 2020
Q1 2020 Flexion Therapeutics Inc Earnings Call
Is Flexion Therapeutics (FLXN) a Smart Long-term Buy?
02:23pm, Thursday, 11'th Jun 2020
Miller Value Partners recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Miller Value Partners Opportunity Equity Fund posted a return of -38.4% for the quarter
Flexion (FLXN) Soars: Stock Adds 6.6% in Session
01:13pm, Thursday, 28'th May 2020
Flexion (FLXN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
